The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Alnylam Pharmaceuticals Inc

Nasdaq: ALNY
Last

(U.S.) $100.73

Today's change+3.52 +3.62%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Alnylam Pharmaceuticals Inc

Nasdaq: ALNY
Last

(U.S.) $100.73

Today's change+3.52 +3.62%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Alnylam Pharmaceuticals Inc up sharply

Alnylam Pharmaceuticals Inc closed up sharply Wednesday, rallying (U.S.)$3.52 or 3.62% to (U.S.)$100.73. Over the last five days, shares have gained 12.46% and 56.66% year to date. Shares have outperformed the S&P 500 by 50.10% during the last year.

Key company metrics

  • Open(U.S.) $97.55
  • Previous close(U.S.) $97.21
  • High(U.S.) $100.81
  • Low(U.S.) $97.26
  • Bid / Ask-- / --
  • YTD % change+56.66%
  • Volume335,072
  • Average volume (10-day)589,310
  • Average volume (1-month)643,288
  • Average volume (3-month)741,236
  • 52-week range(U.S.) $47.03 to (U.S.) $112.57
  • Beta1.65
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$5.37
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue117811
Total other revenue--------
Total revenue117811
Gross profit--------
Total cost of revenue--------
Total operating expense565227740
Selling / general / administrative101298
Research & development464126832
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-45-45-269-30
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-44-44-269-29
Income after tax-44-44-251-32
Income tax, total00-183
Net income-44-44-251-32
Total adjustments to net income--------
Net income before extra. items-44-44-251-32
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-44-44-251-32
Inc. avail. to common incl. extra. items-44-44-251-32
Diluted net income-44-44-251-32
Dilution adjustment000--
Diluted weighted average shares76766863
Diluted EPS excluding extraordinary itemsvalue per share-0.58-0.58-3.70-0.51
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.58-0.58-3.70-0.51